Picture of Steris logo

STE Steris News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

REG-BARCLAYS PLC FORM 8.3 - STERIS CORPORATION <Origin Href="QuoteRef">BARC.L</Origin> <Origin Href="QuoteRef">STE.N</Origin>

FORM 8.3 - STERIS CORPORATION

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the Code)

1. KEY INFORMATION

(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose STERIS CORPORATION
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 30 October 2015
(f) In addition to the company in 1(c) above, is the discloser making NO
disclosures in respect of any other party to the offer?

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: ORD
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 32,080 0.05% 349,917 0.58%
(2) Cash-settled derivatives:
327,312 0.55% 0 0.00%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
(4)
TOTAL: 359,392 0.60% 349,917 0.58%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form8 (Open Positions).

(b) Rights to subscribe for new securities (including directors and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security Purchase/sale Number of securities Price per unit

(b) Cash-settled derivative transactions

Class of relevant Purchase/sale Number of Price per unit
security securities
ORD Purchase 10 75.0150 USD
ORD Purchase 11 75.6700 USD
ORD Purchase 24 74.5845 USD
ORD Purchase 28 74.8400 USD
ORD Purchase 100 73.3700 USD
ORD Purchase 100 75.1350 USD
ORD Purchase 100 75.0100 USD
ORD Purchase 100 74.5200 USD
ORD Purchase 100 74.3000 USD
ORD Purchase 100 73.9200 USD
ORD Purchase 100 73.7900 USD
ORD Purchase 100 73.7800 USD
ORD Purchase 100 73.7400 USD
ORD Purchase 100 73.5700 USD
ORD Purchase 100 75.1400 USD
ORD Purchase 150 74.2200 USD
ORD Purchase 200 74.1950 USD
ORD Purchase 200 73.8600 USD
ORD Purchase 200 73.8350 USD
ORD Purchase 200 74.9900 USD
ORD Purchase 210 75.0385 USD
ORD Purchase 270 74.0024 USD
ORD Purchase 300 73.9833 USD
ORD Purchase 300 74.3823 USD
ORD Purchase 300 74.6200 USD
ORD Purchase 400 74.3025 USD
ORD Purchase 400 73.7325 USD
ORD Purchase 496 73.8397 USD
ORD Purchase 496 73.5761 USD
ORD Purchase 500 73.0000 USD
ORD Purchase 508 74.9523 USD
ORD Purchase 591 74.6197 USD
ORD Purchase 600 74.9633 USD
ORD Purchase 698 73.6576 USD
ORD Purchase 743 73.6525 USD
ORD Purchase 800 73.9062 USD
ORD Purchase 800 74.7068 USD
ORD Purchase 1,170 74.9500 USD
ORD Purchase 1,300 74.0292 USD
ORD Purchase 1,300 75.0015 USD
ORD Purchase 1,320 73.6015 USD
ORD Purchase 1,396 73.6352 USD
ORD Purchase 1,500 74.1200 USD
ORD Purchase 1,696 73.7523 USD
ORD Purchase 1,800 74.2319 USD
ORD Purchase 1,940 74.9070 USD
ORD Purchase 2,017 74.4196 USD
ORD Purchase 2,150 73.9481 USD
ORD Purchase 2,792 74.1518 USD
ORD Purchase 3,200 74.5642 USD
ORD Purchase 3,574 73.6770 USD
ORD Purchase 3,600 74.2698 USD
ORD Purchase 3,779 73.8360 USD
ORD Purchase 3,800 74.2593 USD
ORD Purchase 4,250 74.1072 USD
ORD Purchase 5,400 73.9386 USD
ORD Purchase 7,808 74.0236 USD
ORD Purchase 7,844 73.8314 USD
ORD Purchase 8,400 73.4000 USD
ORD Purchase 8,982 74.5199 USD
ORD Purchase 11,043 73.8452 USD
ORD Purchase 11,728 74.0819 USD
ORD Purchase 11,850 74.3744 USD
ORD Purchase 13,204 74.2052 USD
ORD Purchase 13,277 73.9016 USD
ORD Purchase 14,745 73.4235 USD
ORD Purchase 16,400 74.4726 USD
ORD Purchase 21,082 74.4854 USD
ORD Purchase 39,600 74.1849 USD
ORD Purchase 40,000 70.0000 USD
ORD Purchase 41,097 73.5170 USD
ORD Purchase 61,032 73.5891 USD
ORD Purchase 176,877 73.9396 USD
ORD Sale 100 71.5100 USD
ORD Sale 100 74.8400 USD
ORD Sale 100 71.6550 USD
ORD Sale 100 73.3700 USD
ORD Sale 111 74.2981 USD
ORD Sale 129 73.0700 USD
ORD Sale 141 72.7653 USD
ORD Sale 200 71.8700 USD
ORD Sale 200 74.6600 USD
ORD Sale 244 74.3386 USD
ORD Sale 254 74.9523 USD
ORD Sale 270 74.0024 USD
ORD Sale 389 74.6184 USD
ORD Sale 400 74.7825 USD
ORD Sale 400 71.6575 USD
ORD Sale 411 73.2928 USD
ORD Sale 500 73.3850 USD
ORD Sale 706 74.8024 USD
ORD Sale 900 71.5861 USD
ORD Sale 900 74.3960 USD
ORD Sale 1,000 74.9056 USD
ORD Sale 1,194 74.9500 USD
ORD Sale 1,227 73.1289 USD
ORD Sale 1,500 71.6730 USD
ORD Sale 1,700 74.5047 USD
ORD Sale 2,017 74.9856 USD
ORD Sale 2,800 74.1414 USD
ORD Sale 2,952 74.9477 USD
ORD Sale 3,800 74.4778 USD
ORD Sale 4,475 74.4556 USD
ORD Sale 4,481 74.1055 USD
ORD Sale 5,199 74.3796 USD
ORD Sale 6,891 74.6938 USD
ORD Sale 6,945 73.4500 USD
ORD Sale 8,422 74.1474 USD
ORD Sale 8,700 74.8048 USD
ORD Sale 10,206 74.0196 USD
ORD Sale 10,265 71.9703 USD
ORD Sale 11,588 74.1118 USD
ORD Sale 11,868 74.1117 USD
ORD Sale 13,634 73.9941 USD
ORD Sale 14,000 73.9289 USD
ORD Sale 14,600 74.2608 USD
ORD Sale 16,100 73.4000 USD
ORD Sale 16,700 73.9986 USD
ORD Sale 16,850 74.3793 USD
ORD Sale 16,984 74.0999 USD
ORD Sale 35,900 74.2721 USD
ORD Sale 40,000 70.0000 USD
ORD Sale 40,801 74.4839 USD
ORD Sale 98,645 73.4806 USD
ORD Sale 103,689 73.8658 USD

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding,
formal or informal, relating to relevant securities which may be an inducement to deal
or refrain from dealing entered into by the person making the disclosure and any party
to the offer or any person acting in concert with a party to the offer:
NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between
the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights of future acquisition or disposal of any relevant securities to which
any derivative is referenced:
NONE

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 2 Nov 2015
Contact name: Jay Supaya
Telephone number: 020 7773 0635

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panels Market Surveillance Unit is available for consultation in relation to the Codes disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panels website at www.thetakeoverpanel.org.uk.

BARCLAYS PLC

Recent news on Steris

See all news